The potential benefits of rapid-acting insulin analogs versus regular human insulin are that the analogs have earlier onset and peak of biologic activity, resulting in lower postprandial glucose levels; a shorter duration of action, resulting in less late-prandial hypoglycemia; and less biologic variab...
Traditionally, approximately 24 insulin the basal but both forms out had an onset of ac- provided coverage, any peaks. Glargine average do not mimic the normal More re- tion of 1.5 hours with 0.8 hours for body's physiology. compared NPH, continuous subcutaneous insulin infusion...
this is the key difference between NPH and regular insulin. Moreover, NPH has a slower onset phase but lasts for a longer period of time. Regular insulin has a rapid onset but wears off in shorter time periods. Besides
The potential benefits of rapid-acting insulin analogs versus regular human insulin are that the analogs have earlier onset and peak of biologic activity, resulting in lower postprandial glucose levels; a shorter duration of action, resulting in less late-prandial hypoglycemia; and less biologic variab...